Trexquant Investment LP Coherus Bio Sciences, Inc. Transaction History

Trexquant Investment LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $65,555 - $126,813	-9,143 Reduced 28.27%	23,204 $223,000
Q2 2022 Aug 11, 2022	SELL	$5.86 - $13.23 $42,947 - $96,962	-7,329 Reduced 18.47%	32,347 $234,000
Q1 2022 May 13, 2022	BUY	$10.92 - $16.41 $243,210 - $365,483	22,272 Added 127.97%	39,676 $512,000
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $275,157 - $330,501	17,404 New	17,404 $278,000
Q2 2021 Aug 12, 2021	SELL	$12.95 - $15.41 $426,663 - $507,713	-32,947 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$14.42 - $21.39 $475,095 - $704,736	32,947 New	32,947 $481,000
Q3 2020 Nov 06, 2020	SELL	$17.41 - $19.89 $333,436 - $380,933	-19,152 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$14.43 - $19.16 $276,363 - $366,952	19,152 New	19,152 $342,000
Q3 2019 Nov 08, 2019	SELL	$16.3 - $23.37 $410,971 - $589,227	-25,213 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$13.1 - $22.1 $52,098 - $87,891	3,977 Added 18.73%	25,213 $557,000
Q1 2019 May 13, 2019	BUY	$8.38 - $15.5 $177,957 - $329,158	21,236 New	21,236 $290,000
Q4 2018 Feb 13, 2019	SELL	$8.65 - $16.28 $616,450 - $1.16 Million	-71,266 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$14.45 - $20.25 $852,781 - $1.2 Million	59,016 Added 481.76%	71,266 $1.18 Million
Q2 2018 Aug 07, 2018	SELL	$10.25 - $17.45 $235,770 - $401,384	-23,002 Reduced 65.25%	12,250 $172,000
Q1 2018 May 03, 2018	BUY	$9.1 - $13.7 $320,793 - $482,952	35,252 New	35,252 $390,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.